Intellectual Property

Finally, a key component to the commercialization strategy for the TAML activators is a strong intellectual property portfolio. Along these lines, I am co-inventor on six of the US Patents related to TAML oxidant activators; currently, the University owns nine US patents and in excess of sixty issued or allowed international patents. A listing of my patents can be found here.